AHA Comments on FDA Draft Guidance on Mixing, Diluting, or Repackaging Biological Products

Docket No. FDA-2014-D-1525: Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application; Draft Guidance for Industry

Key Resources

Related Resources

Advancing Health Podcast
Closing the Gap: How Duke University Is Fighting Hypertension Through Community Collaboration
Public
AHA Center for Health Innovation Market Scan
3 Health Care Takeaways from Google I/O 2025
Public
AHA Center for Health Innovation Market Scan
Why Rural Hospitals May Have Some Advantages to Drive Tech Innovation
Public
Advisory
New AHA Report Finds Workplace and Community Violence Costs Hospitals More than $18 Billion Annually
Member
Advancing Health Podcast
Bringing Virtual Behavioral Health Care Access to Rural Youth in West Virginia
Public
Special Bulletin
Register for June 17 AHA Advocacy Day in Washington, D.C.
Member